Back to Search Start Over

First Report and Comparative Genomics Analysis of a bla OXA-244 -Harboring Escherichia coli Isolate Recovered in the American Continent.

Authors :
Abril D
Bustos Moya IG
Marquez-Ortiz RA
Josa Montero DF
Corredor Rozo ZL
Torres Molina I
Vanegas Gómez N
Escobar-Perez J
Source :
Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2019 Nov 13; Vol. 8 (4). Date of Electronic Publication: 2019 Nov 13.
Publication Year :
2019

Abstract

The carbapenemase OXA-244 is a derivate of OXA-48, and its detection is very difficult in laboratories. Here, we report the identification and genomic analysis of an Escherichia coli isolate (28Eco12) harboring the bla <subscript>OXA-244</subscript> gene identified in Colombia, South America. The 28Eco12 isolate was identified during a retrospective study, and it was recovered from a patient treated in Colombia. The complete nucleotide sequence was established using the PacBio platform. A comparative genomics analysis with other bla <subscript>OXA-244</subscript> -harboring Escherichia coli strains was performed. The 28Eco12 isolate belonged to sequence type (ST) 38, and its genome was composed of two molecules, a chromosome of 5,343,367 bp and a plasmid of 92,027 bp, which belonged to the incompatibility group IncY and did not harbor resistance genes. The bla <subscript>OXA-244</subscript> gene was chromosomally encoded and mobilized by an ISR1-related Tn 6237 composite transposon. Notably, this transposon was inserted and located within a new genomic island. To our knowledge, this is the first report of a bla <subscript>OXA-244</subscript> -harboring Escherichia coli isolate in America. Our results suggest that the introduction of the OXA-244-producing E. coli isolate was through clonal expansion of the ST38 pandemic clone. Other isolates producing OXA-244 could be circulating silently in America.

Details

Language :
English
ISSN :
2079-6382
Volume :
8
Issue :
4
Database :
MEDLINE
Journal :
Antibiotics (Basel, Switzerland)
Publication Type :
Academic Journal
Accession number :
31766210
Full Text :
https://doi.org/10.3390/antibiotics8040222